# CORRESP — Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU) (CIK 0002040475) > Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU) (CIK 0002040475) → SEC staff · filed 2025-09-22 · ticker DMII, DMIIR, DMIIU · SIC 6770 ## What is this A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters. ## Key facts - **Accession number:** 0001213900-25-089929 - **Form:** CORRESP - **Filer:** Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU) (CIK 0002040475) - **CIK:** 0002040475 - **Ticker:** DMII, DMIIR, DMIIU - **Filed:** 2025-09-22 - **SIC industry:** 6770 - **HQ:** Fort Lauderdale, FL ## Primary source PDF letter: https://www.sec.gov/Archives/edgar/data/2040475/000121390025089929/filename1.htm EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2040475&type=UPLOAD&dateb=&owner=include&count=40 ## Other comment-letter activity for Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU) (CIK 0002040475) - CORRESP — 2025-09-22 — /comment-letter/0001213900-25-089923 - CORRESP — 2025-09-16 — /comment-letter/0001213900-25-088056 - UPLOAD — 2025-09-15 — /comment-letter/0000000000-25-009970 ## Citation > US Securities and Exchange Commission, EDGAR CORRESP comment letter, Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU) (CIK 0002040475) (CIK 0002040475), filed 2025-09-22, accession 0001213900-25-089929. Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/comment-letter/0001213900-25-089929. --- *[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*